BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.
Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries.
Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.
From the 7th Annual BioHealth Capital Region Forum - Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP)
The session from the BioHealth Capital Region Forum focuses on a vision for a new science entity, the Advanced Research Projects Agency for Health (ARPA-H). This new NIH Institute would accelerate biomedical innovation and adoption of technologies and approaches to revolutionize healthcare and medicine.
Tara A. Schwetz, Ph.D. is the Assistant Director for Biomedical Science Initiatives in the White House Office of Science and Technology Policy (OSTP). She is currently on detail to OSTP from her role as Associate Deputy Director (ADEPD), National Institutes of Health (NIH). During her tenure as ADEPD, Dr. Schwetz also served as the acting Director of the National Institute of Nursing Research (NINR). Prior to assuming these roles, she was the Chief of the Strategic Planning and Evaluation Branch in the Office of the Director at the National Institute of Allergy and Infectious Diseases (NIAID). Dr. Schwetz led several efforts while at NIAID, including conducting an evaluation of the Centers of Excellence for Influenza Research and Surveillance to facilitate evidence-based decision-making and developing the NIAID Strategic Plan for Tuberculosis Research. Previously, Dr. Schwetz served as the Senior Advisor to the Principal Deputy Director of NIH (DEPD), where she coordinated efforts such as Reimagine HHS, the NIH rigor and reproducibility activities, and the first NIH-Wide Strategic Plan. Dr. Schwetz also served in the dual role of the NIH Environmental influences on Child Health Outcomes (ECHO) Interim Associate Program Director and the Special Assistant to the DEPD. Prior to these roles, she was a Health Science Policy Analyst at the National Institute of Neurological Disorders and Stroke, where she helped develop the National Pain Strategy. Dr. Schwetz started her career at NIH as an AAAS Science and Technology Policy Fellow at NINR. She received a BS in biochemistry with honors from Florida State University and a PhD in biophysics from the University of South Florida, followed by a postdoctoral fellowship at Vanderbilt University.
From the 7th Annual BioHealth Capital Region Forum - Dr. Anthony Fauci
Rich Bendis, President and CEO of BioHealth Innovation conducts a fireside chat with Dr. Anthony Fauci, Director of the National Institute for Allergy and Infectious Disease (NIAID) since 1984. Dr. Fauci oversees an annual budget of over $6 Billion and has advised 7 President’s on many domestic and global health issues. He has an extensive portfolio of basic and applied research to prevent, diagnose and treat many existing and emerging infectious diseases.
The fireside chat includes a discussion on Dr. Fauci’s personal background and interest in healthcare issues, his role at NIAID and serving the Administration, the importance of NIH to the Country and the BioHealth Capital Region and career opportunities at NIAID and NIH. They also discuss the Covid 19 Pandemic and recommendations to address proactive measures to reduce the impact of potential future pandemics.
Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc.
Dr. Xavier Barril, Chief Scientific Officer, Gain Therapeutics, and Hartaj Singh, Managing Director and Senior Analyst, Oppenheimer & Co. Inc., Join BioTalk to discuss Artificial Intelligence and Machine Learning in Drug Discovery, and Wall Street’s Views on this Exciting Science.
Lily Qi, Maryland State Delegate
Lily Qi, Representative for the 15th legislative district in the Maryland House of Delegates. Joins BioTalk to discuss her career, Biotech in Montgomery County, and being a supporter of the BioHealth Capital Region
Reverse BioTalk – Jeff Galvin, CEO of American Gene Technologies Interviews Rich Bendis, CEO and President of BioHealth Innovation, Inc.
Jeff Galvin, CEO of American Gene Technologies and Rich Bendis, CEO and President of BioHealth Innovation, Inc. have a fireside chat about the rapid evolution of the BioHealth Capital Region.
On the heels of Silicon Valley’s branding as one of the world’s largest tech hubs, the BioHealth Capital Region aims to brand the DMV region as one of the most prominent BioHealth clusters in the Mid-Atlantic. BioHealth Innovation, Inc. was founded 11 years ago in an effort to drive ideas from labs into markets through innovation-driven economic development organizations and initiatives.
Galvin and Bendis discuss the abundance of opportunities for growth within the region as it is home to a wide variety of research institutions, top scientists, and annual grants. Additionally, they discuss how BioHealth Innovation, Inc. cultivates success for companies within the competitive region.
For more information on BioHealth Innovation, go to:
If you like this video, please subscribe to our channel: youtube.com/channel/UCqRz...
Also, please leave us a comment to let us know how you liked it as well as any additional subjects you’d like us to cover.
American Gene Technologies (AGT) is a clinical-stage, gene and cell therapy company in Rockville, Maryland with a proprietary gene-delivery platform for rapid drug development of infectious diseases, cancers, and inherited disorders. AGT's mission is to transform people's lives through genetic medicines that rid the body of disease.
Paul Rennie, OBE and Professor Jason Snape
Paul Rennie, OBE, Counsellor for Global Issues in the Global Economy Group at the British Embassy, Washington DC, and Professor Jason Snape, Head of Environmental Protection within AstraZeneca’s Global Sustainability Team, Join BioTalk Host and BioHealth Innovation President and CEO, Rich Bendis to Discuss Life Sciences, Climate Change, COP26, and The Race to Zero Campaign.
Insights into the mid Atlantic BioHealth sector
A great insiders view of biotech players in the DC region.
Great podcast about BioHealth Capital Region
Excellent resource for anyone looking to learn about the leaders, challenges and missions of the members of the BioHealth Capital Region; the biotech, academic and government research community, as well as the pharmaceutical and manufacturing industry of the D.C. metropolitan area.